Der blev vist non- inferiority for AZARGA sammenlignet med dorzolamid 20 mg/ ml + timolol 5 mg/ ml i den gennemsnitlige IOP- reduktion på alle tidspunkter ved alle besøg.
The non-inferiority of AZARGA as compared to dorzolamide 20 mg/ml + timolol 5 mg/ml in the mean IOP reduction was demonstrated across all time-points at all visits.